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َمَوُه السََّلى كمتنبئ لتعسر نتائج احلمل
 كوكب تا�صفيني واإلهام مو�صى حمدي
َلى املتكررة يف احلمل املفرد، حتليل العوامل املرتبطة باملخاطر املتعلقة  الهدف: تهدف هذه الدرا�صة اإىل التحقق من َمَوُه ال�صَّ امللخ�ص: 
باحلمل وتقييم النتائج المومية والولدية امل�صادة . الطريقة: مت القيام بدرا�صة اإ�صتعادية ملجموعة احلالت املوؤديه اىل تعقيدات داء موه 
ال�صلى فى كل حالت احلمل املفرد بعد الأ�صبوع 28 من احلمل. مت اإجراء هذه الدرا�صة يف ق�صم الن�صاء والولدة مب�صت�صفى نزوى، عمان من 
يناير 2002 اإىل دي�صمرب 2007. من عدد 25,979 حالة حمل مت ا�صتعرا�صها، وجد اأن 477 تعاين من داء موه ال�صلى. جمموعة التحكم 
تكونت من 900 امراأة حامل. حالت داء موه ال�صلى مت ت�صخي�صها على اأنها خفيفة، معتدلة اأو �صديدة م�صتندة على موؤ�رس الكمية الق�صوى 
من ال�صائل ال�صلوي. متت املقارنة بني احلالت امل�صابة وجمموعة التحكم طبقا للبيانات ال�صكانية، داء ال�صكر، داء عملقة اجلنني، الولدة 
القي�رسية، تكرار الأجنة ال�صاذة و معدل وفيات الأجنة. النتائج: مت ت�صخي�ض داء موه ال�صلى يف %1.8 من معدل الن�صاء احلوامل . وكانت 
خفيفة يف 382 حالة)%80(، معتدلة يف 84 حالة )%17.6( و�صديدة يف 12 حالة )%2.4(. 72)%15.3( حالة من اإجمايل حالت 
وجود  مع  التحكم،  جمموعة  يف   10% ب  مقارنة  امل�صخ�ض(  ال�صكري  اأو  )احلملي  ال�صكري  بداء  بالإ�صابة  معقدة  كانت  ال�صلى  موه  داء 
39)%8.1( وليد م�صاب بت�صوهات خلقية. داء موه ال�صلى كان مرتبط بتقدم عمر الأم ، وكان عمر 58)%12.2( من احلالت اأكرب من 
40 �صنة. معدل وفيات املواليد يف احلوامل امل�صابات بداء موه ال�صلى كانت 42 حالة لكل 1000 مولود مقارنة ب 14 حالة لكل 1000 
اخلال�صة: هذه البيانات ت�صري اإىل وجود ارتباط بني داء موه ال�صلى وزيادة خماطر النتائج العك�صية للحمل،  مولود يف جمموعة التحكم. 
وكذلك وجود عالقة اإيجابية فيما يتعلق بعمر الأم، الإ�صابة بداء ال�صكري، ت�صوهات اجلنني وداء عملقة اجلنني.
مفتاح الكلمات: موؤ�رس ال�صائل ال�صلوي، الولدة القي�رسية، عملقة اجلنني، النتيجة الولدية، عمان.
abstract: Objectives: This study aimed to ascertain the frequency of polyhydramnios in singleton pregnancies, 
to determine the associated risk factors, and assess the adverse maternal and perinatal outcomes. Methods: A 
retrospective cohort study of all singleton pregnancies complicated with polyhydramnios after 28 weeks of gestation 
was carried out in Nizwa Hospital’s Obstetrics & Gynecology Department, Oman, from January 2002 to December 
2007. Of 25,979 pregnant women reviewed, 477 were found to have polyhydramnios. The control group consisted 
of 900 pregnant women. Cases of polyhydramnios were diagnosed as mild, moderate, or severe based on their 
highest amniotic fluid index. Cases were compared with controls in terms of demographic data; prevalence of 
diabetes, macrosomia, or Caesarean deliveries; frequency of fetal anomalies, and perinatal mortality rate. Results: 
Polyhydramnios was diagnosed in 1.8% of pregnancies. It was mild in 382 (80%), moderate in 84 (17.6%), and severe 
in 12 (2.4%). A total of 72 (15.3 %) cases of polyhydramnios were complicated by diabetes (gestational or established 
diabetes mellitus) as compared to 10% of the control group and 39 (8.1%) neonates had congenital anomalies. 
Polyhydramnios was associated with advanced maternal age; 58 (12.2%) of subjects were over 40 years old. The 
perinatal mortality rate with polyhydramnios was 42 per 1,000 births compared to 14 per 1000 births in the control 
group. Conclusion: These data demonstrate that polyhydramnios is associated with an increased risk of adverse 
perinatal outcomes, and there is a significant positive relation with maternal age, diabetes, fetal anomalies, and fetal 
macrosomia.
Keywords: Amniotic fluid index; Caesarean delivery; Macrosomia; Perinatal outcome; Oman.
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Advances in Knowledge
- Polyhydramnios occurs in 1–3.5% of pregnancies and is severe in 2.4% of these.
- The principal factors associated with polyhydramnios includes fetal malformation, maternal diabetes mellitus, and multiple gestations.
- The majority of cases of polyhydramnios are idiopathic.
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Polyhydramnios refers to an excessive accumulation of amniotic fluid, which is associated with an increased risk 
of adverse pregnancy outcomes.1 Polyhydramnios 
is diagnosed when a mother’s amniotic fluid index 
elevates to >24 ± 2 cm standard deviation (SD) in 
the late second or third trimester.2 It complicates 
0.4–1.9% of all pregnancies.3 The aetiology of 
polyhydramnios is diverse and involves many 
maternal and fetal conditions including diabetes, 
congenital anomalies, multiple gestation, and 
isoimmunisation. If none of these causes can 
be identified, then a diagnosis of idiopathic 
polyhydramnios is made. Magann reported the 
incidence of idiopathic polyhydramnios among 
subjects with polyhydramnios as 50–60%.4 
However, it consistently has been documented that 
perinatal morbidity and mortality rates increased in 
association with polyhydramnios related to specific 
causes.5,6
A pregnancy complicated by polyhydramnios 
can present difficult diagnostic and therapeutic 
dilemmas for obstetricians. Many clinicians have 
viewed polyhydramnios as a prognostic factor of 
increased risk of pregnancy complications and have 
recommended an extensive evaluation of these 
pregnancies, including multiple comprehensive 
ultrasound examinations, repeat diabetes 
screening, and amniocentesis for fetal karyotyping. 
However, counselling of a couple regarding 
idiopathic polyhydramnios often creates significant 
anxiety and fosters the impression of an abnormal 
pregnancy.7
The rationale of our study was to determine the 
association between polyhydramnios and adverse 
obstetric and perinatal outcomes in singleton, 
third-trimester pregnancies.
Methods
This was a retrospective cohort study of 25,979 
women with singleton pregnancies who delivered 
at Nizwa Hospital between January 2002 and 
December 2007. Permission was first gained from 
the Research and Ethics Committee of Nizwa 
Hospital, which is a secondary care hospital serving 
as a regional referral center for the Al-Dakhliya 
central region in Oman. The study group was 
composed of 477 women with polyhydramnios, 
while 900 women with normal amniotic fluid levels 
formed the control group, which was selected 
randomly.
Included in the study were women at 28 or more 
weeks’ gestation with confirmed polyhydramnios in 
singleton pregnancies who had been diagnosed by 
ultrasound examination. Pregnancies of less than 
28 weeks’ gestation and multiple pregnancies were 
excluded.
Polyhydramnios was categorised as mild, 
moderate, or severe based on an amniotic fluid 
index of 25–30 cm, 30.1–35 cm, or 35.1 cm or 
more, respectively.8
Pregnancies were evaluated using abdominal 
ultrasound examinations as a part of routine fetal 
surveillance in the third trimester of pregnancies 
by realtime ultrasound equipment with a 3.5 
MHz curve linear array transducer (Koninklijke 
Philips Electronics, Eindhoven, Netherlands). The 
frequency of the following were also measured 
during the study: congenital anomalies, macrosomia 
(defined as a birthweight of ≥ 4000 grams), preterm 
deliveries (defined as birth occurring from 24 + 
0 weeks to less than 36 + 6 weeks of gestation), 
Caesarean delivery rates, and perinatal mortality 
(defined as all stillbirths and deaths in the first week 
after birth).9,10
When polyhydramnios was diagnosed, an 
ultrasound examination was done to detect possible 
structural anomalies. A 75 gram 2 hour oral 
glucose tolerance test was carried out in all women 
without pre-existing diabetes mellitus. Diagnosis 
of gestational diabetes was confirmed according to 
Oman’s national and WHO guidelines (a fasting cut 
off value of >5.8 m mol/L or above, 2 hour value 
>7.8 m mol/L or above). Cases and controls 
were compared for maternal characteristics 
 Application to Patient Care
- The obstetrician needs to consider a thorough evaluation of the fetus for congenital anomalies when mothers suffer from polyhydramnios 
during pregnancy.
- Close attention should be paid during the antepartum, intrapartum and postpartum periods to anticipate complications of 
polyhydramnios.
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Table 1: Demographic data of study subjects





n % n %
Nulliparous 90 18.9 130 14.5 0.31
Multiparous 287 60.2 560 62.2 0.15
Grand multiparous 100 20.9 210 23.3 0.26
Mean maternal age (years) 30.1 ± 5.1 NS 28.2 ± 4.3 NS NS
Maternal age >40 years 58 12.2 34 3.7 <0.001
Diabetes mellitus 73 15.3 89 9.8 <0.001
NS = non-significant
Grand multiparity = >6 parity; Multiparous = 2–6 parity; Nulliparous = 0 parity.
Table 2: Outcome measures for study subjects
Outcome measure Polyhydramnios (n = 477) Control (n = 900) P value
n % n %
Preterm delivery(<37 weeks) 20 4.1 60 6.6 0.62
Macrosomia (>4000 g) 90 18.8 50 5.5 <0.003
Caesarean delivery 115 24.0 96 10.6 <0.001
Congenital anomalies 39 8.2 39 4.3 <0.001
Perinatal mortality rate 42/1000 14/1000 <0.001
and risk factors known to be associated with 
polyhydramnios, including diabetes, macrosomia, 
and congenital anomalies.
Caesarean delivery rates and perinatal outcomes 
in the study group were compared with those of the 
control group. Neonatal information was obtained 
using the computerised obstetric database, which 
contains pregnancy outcomes for all women who 
have delivered at our hospital. Evaluation for major 
congenital anomalies was routinely carried out 
in the immediate neonatal period by attending 
pediatricians. Karyotype analysis was performed at 
the pediatricians’ discretion. No women had genetic 
amniocentesis during the antenatal period as we do 
ot have the facilities for such testing. The control 
group included singleton pregnancies at ≥28 weeks 
of gestation who were evaluated during the study 
period and exhibited normal amniotic fluid levels 
upon ultrasound. 
The Statistical Package for the Social Sciences 
(SPSS), Version 10 (IBM, Inc., Chicago, Illinois, 
USA) was used for statistical analysis. The rate of 
each specific outcome measure was calculated 
for patient and control subjects and rates were 
compared with Pearson’s chi-square test. Statistical 
significance was defined as P <0.05.
Results  
Of the 25,979 singleton pregnancies seen at the 
hospital during the study period, 477 (1.8%) were 
diagnosed with polyhydramnios by ultrasound 
scan. Of those diagnosed, the severity was classified 
as mild, moderate, and severe in 80.1%, 17.6%, and 
2.4% of cases, respectively. From our data, we were 
able to determine three prominent aetiological 
classifications of polyhydramnios: idiopathic 
polyhydramnios occurring in 76.8% of cases; 
diabetes mellitus, occurring in 15.3% of cases; and 
congenital anomalies, found in 8.2% of cases.
The demographic data for the control and 
study groups are displayed in Table I. There was a 
significant rise in polyhydramnios with advanced 
maternal age (P <0.001). The analysis of parity 
distribution did not reveal any significant trend 
with polyhydramnios. 
The cohorts of women were evaluated for 
diabetes, maintaining the view that there is an 
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established association between diabetes and 
polyhydramnios. The prevalence of diabetes 
in the control group was 9.8%, while in the 
polyhydramnios group it was 15.3% (P <0.001) 
[Figure 1]. Of those patients, 59 were on a medically 
supervised diet and 12 were on insulin. Only two 
patients had pre-existing diabetes, as shown in 
Figure 1. The difference is statistically significant.
There were 115 Caesarean sections in the study 
group, yielding a 24% rate of Caesarean delivery 
versus a 10.6% rate in the control group (P <0.001), 
as shown in Figure 2. Eight (1.6%) of those in the 
study group had instrumental delivery as compared 
to 2.4% in the control group. Most of those were 
vacuum deliveries. Outcome measures are shown 
in Table 2. 
As regards neonatal and fetal outcomes, 
Figure 3 details the major congenital anomalies 
that were detected in the infants of 39 women 
with polyhydramnios (8.2%), while in the control 
group 4.3% displayed anomalies (P <0.001). 
Central nervous system (CNS) anomalies included 
hydrocephaly, anencephaly, holoprosencephaly, 
and myelomeningocele; these were diagnosed in 12 
pregnancies. Gastrointestinal anomalies included 
oesophageal and duodenal atresia, diaphragmatic 
hernia, and trachea esophageal fistula; they were 
diagnosed in 10 pregnancies. Eight pregnancies had 
cardiovascular malformations including structural 
cardiac defect, hydrops, and pulmonary oedema. 
Four fetuses had multi-organ system malformations 
including those of the central nervous system, and 
the gastrointestinal and genitourinary systems. 
Inherited disorders of renal functioning are a rare 
cause of polyhydramnios. In our study, we diagnosed 
one baby with Bartter syndrome whose mother had 
uncontrolled diabetes mellitus. The infant died after 
11 days due to associated complex cardiac disease. 
In regard to macrosomia, the mean birth weight 
was 3,800 ± 300 grams in the polyhydramnios group, 
while in the control group it was 3,000 ± 300 grams. 
The heaviest newborn was 5,000 grams, born to a 
7th gravida at 41 weeks of gestation by emergency 
Caesarean section. The incidence of macrosomia in 
the polyhydramnios group was 18.8%, while in the 
control group the incidence was 5.5%. A significant 
positive relationship was observed between 
polyhydramnios and birth weight (P <0.003) [Table 
2]. 
Seventy-six (16.0%) neonates were admitted 
to the Special Care Baby Unit (SCBU) in the 
polyhydramnios group, compared to 11 babies 
(15.5%) from the control group [Figure 4]. Nineteen 
babies of the 76 in the study group had perinatal 
asphyxia and 3 had severe birth asphyxia. The the 
latter babies had multiple congenital anomalies and 
died at the age of 3–4 hours. The other 16 were 
discharged in good condition.
Seven cases of shoulder dystocia were seen in 
the study group, while 11 babies in the control group 
had shoulder dystocia. The average birth weight of 
the babies who had shoulder dystocia was 3.8–4.0 
kg, but none of them had any neurological problem. 
Eleven babies were admitted with hypoglycaemia, 
but only for observation.
The perinatal mortality rate in the 
polyhydramnios group was 42 per 1,000 births as 
compared to 14 per 1,000 births in the control. The 
increased perinatal mortality rate in the case of 
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Figure 1: A comparison of diabetes mellitus between 











Figure 2: A comparison of Caesarean section rates 
between control and polyhydramnios groups.
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the polyhydramnios (i.e. congenital anomalies and 
uncontrolled diabetes). 
Discussion
Recognition of polyhydramnios is of benefit as 
it allows identification of pregnancies that may 
be at increased risk of adverse outcomes. Once 
polyhydramnios is identified, patients need a 
thorough evaluation as it is associated with an 
increased frequency of both maternal and fetal 
complications.11 Chamberlain cited an increased 
rate of perinatal morbidity and mortality among 
patients with hydramnios.6
In reviewing the adverse outcomes in 
pregnancies complicated by polyhydramnios, we 
found the overall incidence of polyhydramnios 
to be 1.8% in our population. Of those who were 
included in our study group, 80% were considered 
to have mild polyhydramnios, 17.6% of the 
cases were considered moderate, and 2.4% were 
considered severe. This is similar to Barnhart’s 
study, which noted polyhydramnios in 1.7% of 2,730 
pregnancies.12
A demographic analysis showed that 
polyhydramnios was more common in older gravida. 
However, parity had no significant relationship to 
polyhydramnios. This was consistent with Mariam’s 
study.12 However, Biggo et al. found a significant 
relationship between both rising maternal age and 
parity in polyhydramnios.13
The association between diabetes and 
polyhydramnios is well known.14 A commonly 
supported theory is that increased amniotic fluid 
volume in diabetic pregnancies could be a result of 
maternal hyperglycemia which, in turn, produces 
fetal hyperglycemia and osmotic diuresis. It has 
consistently been reported that approximately 15% 
of pregnancies complicated by polyhydramnios 
occur in diabetic women.15 This figure was 
consistent with our study. We found that 73 of our 
polyhydramnios patients (15.3%) were diabetic, 
including 59 who were being treated for gestational 
diabetes or were on a medically supervised diet, 
Twelve had gestational insulin-treated diabetes. 
Only two patients had pre-existing diabetes mellitus.
The mean gestational age at delivery was 38.2 
± 1.4 weeks. There was no significant increase in 
preterm delivery as most preterm deliveries were 
noticed in case of severe polyhydramnios due to 
uterine overdistension or fetal anomalies. These 
comprised only 2.5% of the study group. This 
result was consistent with Many, whose study 
showed no increased rate of preterm delivery with 
polyhydramnios.16
The mode of delivery was also influenced 
by polyhydramnios, with a higher proportion 
of Caesarean deliveries as compared with those 
mothers who had a normal volume of amniotic 
fluid. We found a significantly elevated Caesarean 
delivery rate in the polyhydramnios group, which 
had a 24% rate compared to 10.6% in the control 
group. 
In our study, polyhydramnios had an impact 
on perinatal outcomes, the occurrence of fetal 
macrosomia and fetal congenital anomalies, and 
SCBU admissions of neonates. The prevalence of 

























Figure 4: A comparison of neonatal outcomes between 
the polyhydramnios and control groups.












































Figure 3: Incidence of congenital anomalies in 
polyhydramnios. 
CNS = central nervous system; CVS = cardiovascular system.
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with other large series studies. This confirms reports 
of greater anomaly risks that occur with worsening 
polyhydramnios.17 Dashe reported in his study of 
polyhydramnios and anomaly detection that 11.0% 
of the neonates in his study had fetal anomalies.8
In our study, the high incidence of macrosomia 
associated with polyhydramnios was consistent with 
several others studies, and showed a correlation 
between large-for-gestational-age infants and 
polyhydramnios.18
Conclusion
The intention of the study was to compare neonatal 
and maternal outcomes in a control group with 
women with polyhydramnios. Our findings 
suggest that once a diagnosis of polyhydramnios 
is confirmed, a woman should be referred to a 
perinatal centre with expertise in fetal medicine in 
order for any anomalies to be detected. 
This study demonstrates that the likelihood of an 
adverse perinatal outcome increases in association 
with polyhydramnios. There is a significant positive 
relationship between maternal age, diabetes, and 
fetal anomalies and macrosomia. 
Collectively, data from other studies as well as our 
own suggests that if polyhydramnios is diagnosed 
a thorough evaluation for fetal or maternal factors 
is indicated. At minimum, this should include 
a comprehensive ultrasound examination and 
screening for diabetes as it is the most common 
cause of polyhydramnios. Careful maternal and fetal 
surveillance during the antepartum, intrapartum 
and postpartum periods is warranted to anticipate 
complications due to polyhydramnios. 
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